Skip to main content

Table 1 Selected salient clinical data for each patient

From: Basophil sensitivity through CD63 or CD203c is a functional measure for specific immunotherapy

Pt nr Treatment Side effects maintenance dose Ratio CD63 activation at 0,1/1
1 Traditional fatigue 40000 1,07
2 traditional weals 100000 1,05
3 traditional weals 100000 0,82
4 traditional weals, fatigue 100000 0,87
5 traditional, discontinued heartbeat, nervousness (20) 0,78
6 cluster, discontinued itchy tongue (1000) 0,78
7 cluster hyperventilation 100000 0,65
8 cluster none 100000 0,95
9 cluster none 100000 0,66
10 cluster weals, itch, fatigue 100000 0,91
11 cluster weals 100000 0,87
12 cluster none 100000 0,71
13 cluster weals 60000 0,51
14 cluster weals 100000 1,22
15 cluster weals, fatigue 100000 1,00
16 change weals, oedema 100000 0,66
17 change weals, fatigue 100000 0,59
18 change weals 100000 2,09
19 change weals 100000 1,36
20 change weals 100000 1,13
  1. Side effects, maintenance dose and CD63 activation at 0,1 ug/ml venom/1 ug/ml venom are listed against SCIT regimen (traditional 16 week up-dosing protocol/7 week cluster up dosing protocol/change from 7 week to 16 week protocol) applied. Where the ratio of activation exceeds 0,95 it has been shown to be predictive of side effects [7] and is printed bold. Side effects were weals around the site of injection